FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fred Lublin

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Living Beings

Concepts & Ideas

Procedures

Phenomena

Recurrence

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Fred D Lublin; Ponnada A Narayana; Flavia Nelson; Amber R Salter; Jerry S Wolinsky; Stacey S Cofield; Robin Conwit; Gary R Cutter; Tarah Gustafson
Randomized study combining interferon and glatiramer acetate in multiple sclerosis.
James D Weisfeld-Adams; Vikas Bhambhani; Michael C Chicka; Francine R Dembitzer; Wendy J Introne; Fred D Lublin; Lakshmi Mehta; Janet C Rucker; Arnold Szporn; Catherine Cho
Atypical Chédiak-Higashi syndrome with attenuated phenotype: three adult siblings homozygous for a novel LYST deletion and with neurodegenerative disease.
Fred D Lublin
Relapses do not matter in relation to long-term disability: no (they do).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fred Lublin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Fred D Lublin; Ponnada A Narayana; Flavia Nelson; Amber R Salter; Jerry S Wolinsky; Stacey S Cofield; Robin Conwit; Gary R Cutter; Tarah Gustafson
Randomized study combining interferon and glatiramer acetate in multiple sclerosis.
Annals of neurology 2013;73(3):327-40.
2013: James D Weisfeld-Adams; Vikas Bhambhani; Michael C Chicka; Francine R Dembitzer; Wendy J Introne; Fred D Lublin; Lakshmi Mehta; Janet C Rucker; Arnold Szporn; Catherine Cho
Atypical Chédiak-Higashi syndrome with attenuated phenotype: three adult siblings homozygous for a novel LYST deletion and with neurodegenerative disease.
Orphanet journal of rare diseases 2013;8():46.
2011: Fred D Lublin
Relapses do not matter in relation to long-term disability: no (they do).
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(12):1415-6.
2011: J Theodore Phillips; Chris H Polman; Ernie Willoughby; Paul W O'Connor; Amy Pace; William Aschenbach; Gavin Giovannoni; Robert Hyde; Fred D Lublin; Frederick E Munschauer
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(8):970-9.
2011: Paul W O'Connor; A Goodman; Ludwig Kappos; Fred D Lublin; D H Miller; C Polman; R A Rudick; W Aschenbach; N Lucas
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis.
Neurology 2011;76(22):1858-65.
2011: Fred D Lublin; Tracy M DeAngelis
Multiple sclerosis as a model neurologic disease.
The Mount Sinai journal of medicine, New York 2011;78(2):159-60.
2010: Ernst-Wilhelm Radue; William H Stuart; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Richard A Rudick; Fred D Lublin; Bianca Weinstock-Guttman; Daniel R Wynn; Elizabeth Fisher; Athina Papadopoulou; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Journal of the neurological sciences 2010;292(1-2):28-35.
2009: Richard A Rudick; Chris H Polman; Jeffrey A Cohen; M K Walton; A E Miller; Christian Confavreux; Fred D Lublin; Michael Hutchinson; P W O'Connor; S R Schwid; Laura J Balcer; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Assessing disability progression with the Multiple Sclerosis Functional Composite.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(8):984-97.
2009: Michael Hutchinson; Ludwig Kappos; Peter A Calabresi; Christian Confavreux; Gavin Giovannoni; Steven L Galetta; Eva Havrdova; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; Richard A Rudick; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel Wynn; Frances Lynn; Michael A Panzara
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
Journal of neurology 2009;256(3):405-15.
2009: Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; Chris H Polman; Paul W O'Connor; Gavin Giovannoni; J Theodore Phillips; Fred D Lublin; Amy Pace; Richard Kim; Robert Hyde
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study.
Lancet neurology 2009;8(3):254-60.
2008: Tracy DeAngelis; Fred D Lublin
Multiple sclerosis: new treatment trials and emerging therapeutic targets.
Current opinion in neurology 2008;21(3):261-71.
2008: Tracy DeAngelis; Fred D Lublin
Neurotherapeutics in multiple sclerosis: novel agents and emerging treatment strategies.
The Mount Sinai journal of medicine, New York 2008;75(2):157-67.
2007: Peter A Calabresi; Gavin Giovannoni; Christian Confavreux; Steven L Galetta; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; Richard A Rudick; William H Stuart; Fred D Lublin; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.
Neurology 2007;69(14):1391-403.
2007: Richard A Rudick; Deborah Miller; Steve Hass; Michael Hutchinson; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Gavin Giovannoni; Eva Havrdova; Ludwig Kappos; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara
Health-related quality of life in multiple sclerosis: effects of natalizumab.
Annals of neurology 2007;62(4):335-46.
2007: Fred D Lublin
The incomplete nature of multiple sclerosis relapse resolution.
Journal of the neurological sciences 2007;256 Suppl 1():S14-8.
2007: David H Miller; Derek Soon; Kryshani T M Fernando; David G MacManus; Gareth Barker; Tarek A Yousry; Elizabeth Fisher; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ludwig Kappos; Michael Hutchinson; Eva Havrdova; Fred D Lublin; Gavin Giovannoni; Andrzej Wajgt; Richard A Rudick; Frances Lynn; Michael A Panzara; Alfred W Sandrock
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.
Neurology 2007;68(17):1390-401.
2007: Laura J Balcer; Steven L Galetta; Peter A Calabresi; Christian Confavreux; Gavin Giovannoni; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; Richard A Rudick; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.
Neurology 2007;68(16):1299-304.
2006: J Theodore Phillips; Paul W O'Connor; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; David H Miller; Chris H Polman; Fred D Lublin; Gavin Giovannoni; Andrzej Wajgt; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Infusion-related hypersensitivity reactions during natalizumab treatment.
Neurology 2006;67(9):1717-8.
2006: Elliot M Frohman; Eva Havrdova; Fred D Lublin; F Barkhof; A Achiron; Mohammad Sharief; Olaf Stuve; Michael K Racke; Lawrence Steinman; Howard L Weiner; Michael J Olek; Robert Zivadinov; John R Corboy; Cedric S Raine; Gary R Cutter; J Richert; Massimo Filippi
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Archives of neurology 2006;63(4):614-9.
2006: Richard A Rudick; William H Stuart; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Ernst-Wilhelm Radue; Fred D Lublin; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
The New England journal of medicine 2006;354(9):911-23.
2006: Chris H Polman; Paul W O'Connor; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; David H Miller; J Theodore Phillips; Fred D Lublin; Gavin Giovannoni; Andrzej Wajgt; Martin Toal; Frances Lynn; Michael A Panzara; Alfred W Sandrock
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
The New England journal of medicine 2006;354(9):899-910.
2005: Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry Wolinsky
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".
Annals of neurology 2005;58(6):840-6.
2005: Fred D Lublin
Multiple sclerosis trial designs for the 21st century: building on recent lessons.
Journal of neurology 2005;252 Suppl 5():v46-53.
2005: Fred D Lublin
History of modern multiple sclerosis therapy.
Journal of neurology 2005;252 Suppl 3():iii3-iii9.
2005: Mark J Tullman; Fred D Lublin
Combination therapy in multiple sclerosis.
Current neurology and neuroscience reports 2005;5(3):245-8.
2005: Fred D Lublin
Clinical features and diagnosis of multiple sclerosis.
Neurologic clinics 2005;23(1):1-15, v.
2004: Mark J Tullman; R J Oshinsky; Fred D Lublin; Gary R Cutter
Clinical characteristics of progressive relapsing multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(4):451-4.
2004: Jeff Cohen; Gary R Cutter; Fred D Lublin; Steven R Schwid
The MS Co-Operative REsearch (MS-CORE) group: an alternate approach to fostering multicenter studies.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(3):332-3.
2004: A John Petkau; Richard A White; George C Ebers; Anthony T Reder; William A Sibley; Fred D Lublin; Donald W Paty
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(2):126-38.
2004: Mark J Tullman; Fred D Lublin
Evaluating multiple sclerosis.
Journal of the neurological sciences 2004;218(1-2):1-2.
2003: Fred D Lublin; Monika Baier; Gary R Cutter
Effect of relapses on development of residual deficit in multiple sclerosis.
Neurology 2003;61(11):1528-32.
2003: Mark J Tullman; Bradley N Delman; Fred D Lublin; Jesse Weinberger
Magnetic resonance imaging of meningoradiculomyelitis in early disseminated Lyme disease.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2003;13(3):264-8.
2002: Fred D Lublin
When marketing and science intersect: do patients with MS benefit?
Neurology 2002;59(10):1480-1.
2002: Fred D Lublin
The diagnosis of multiple sclerosis.
Current opinion in neurology 2002;15(3):253-6.
2002: Mark J Tullman; Fred D Lublin; Aaron E Miller
Immunotherapy of multiple sclerosis--current practice and future directions.
Journal of rehabilitation research and development 2002;39(2):273-85.
2002: Fred D Lublin
Therapeutic approaches to secondary progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(1):88-90.
2002: D S Goodin; Elliot M Frohman; G P Garmany; J Halper; W H Likosky; Fred D Lublin; D H Silberberg; William H Stuart; S van Den Noort
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines.
Neurology 2002;58(2):169-78.
2001: A B Ben-Zacharia; Fred D Lublin
Palliative care in patients with multiple sclerosis.
Neurologic clinics 2001;19(4):801-27.
2001: W I McDonald; Alastair Compston; Gilles Edan; Donald Goodkin; Hans-Peter Hartung; Fred D Lublin; Henry McFarland; D W Paty; Chris H Polman; Stephen C Reingold; Magnhild Sandberg-Wollheim; William A Sibley; A Thompson; S van Den Noort; B Y Weinshenker; Jerry Wolinsky
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
Annals of neurology 2001;50(1):121-7.
2001: Bernadette Kalman; Fred D Lublin
Spectrum and classification of inflammatory demyelinating diseases of the central nervous system.
Current neurology and neuroscience reports 2001;1(3):249-56.
2001: Fred D Lublin; Stephen C Reingold
Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS.
Annals of neurology 2001;49(5):677-81.
2000: Sidney Croul; Fred D Lublin; Luis Del Valle; R J Oshinsky; A Giordano; Kamel Khalili; C K Ritchie
The cellular response of JC virus T-antigen-induced brain tumor implants to a Murine intra-ocular model.
Journal of neuroimmunology 2000;106(1-2):181-8.
1999: Bernadette Kalman; Fred D Lublin
The genetics of multiple sclerosis. A review.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1999;53(8):358-70.
1999: Donald Goodkin; Stephen C Reingold; W Sibley; Jerry Wolinsky; Henry McFarland; Diane L Cookfair; Fred D Lublin
Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: reporting extended results from phase III clinical trials. National Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Annals of neurology 1999;46(1):132-4.
1999: G P A Rice; George C Ebers; Fred D Lublin; Robert Knobler
Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS.
Neurology 1999;52(9):1893-5.
1999: Gary R Cutter; M L Baier; Richard A Rudick; Diane L Cookfair; Jill Fischer; J Petkau; K Syndulko; B G Weinshenker; J P Antel; Christian Confavreux; G W Ellison; Fred D Lublin; A E Miller; Stephen Rao; Stephen C Reingold; A Thompson; E Willoughby
Development of a multiple sclerosis functional composite as a clinical trial outcome measure.
Brain : a journal of neurology 1999;122 ( Pt 5)():871-82.
1998: Fred D Lublin; Stephen C Reingold
Combination therapy for treatment of multiple sclerosis.
Annals of neurology 1998;44(1):7-9.
1997: J Joseph; Fred D Lublin; R L Knobler
Modulation of T cell-endothelial adhesion by astrocyte conditioned medium.
Glia 1997;21(4):408-12.
1997: Richard A Rudick; J Antel; Christian Confavreux; Gary R Cutter; G Ellison; J Fischer; Fred D Lublin; A Miller; J Petkau; Stephen Rao; Stephen C Reingold; K Syndulko; A Thompson; J Wallenberg; Brian G Weinshenker; E Willoughby
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.
Annals of neurology 1997;42(3):379-82.
1997: Fred D Lublin; Stephen C Reingold
Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: relations between study investigators, advisors, and sponsors. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Neurology 1997;48(3):572-4.
1997: Aaron E Miller; L A Morgante; L Y Buchwald; S M Nutile; Patricia K Coyle; Lauren B Krupp; C A Doscher; Fred D Lublin; R L Knobler; F Trantas; L Kelley; C R Smith; N La Rocca; S Lopez
A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis.
Neurology 1997;48(2):312-4.
1997: Bernadette Kalman; J L Rodriguez-Valdez; U Bosch; Fred D Lublin
Screening for Leber's hereditary optic neuropathy associated mitochondrial DNA mutations in patients with prominent optic neuritis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1997;2(6):279-82.
1997: Bernadette Kalman; Fred D Lublin; Hansjuerg Alder
Impairment of central and peripheral myelin in mitochondrial diseases.
Multiple sclerosis (Houndmills, Basingstoke, England) 1997;2(6):267-78.
1996: Bernadette Kalman; Fred D Lublin; Hansjuerg Alder
Characterization of the mitochondrial DNA in patients with multiple sclerosis.
Journal of the neurological sciences 1996;140(1-2):75-84.
1996: Richard A Rudick; J Antel; C Confavreux; Gary R Cutter; G Ellison; J Fischer; Fred D Lublin; A Miller; J Petkau; Stephen Rao; Stephen C Reingold; K Syndulko; A Thompson; J Wallenberg; B Weinshenker; E Willoughby
Clinical outcomes assessment in multiple sclerosis.
Annals of neurology 1996;40(3):469-79.
1996: Bernadette Kalman; Hansjuerg Alder; U F Bosch; Fred D Lublin; D Chatterjee
The evolutionary relationship among Caucasian MS patients and controls.
Multiple sclerosis (Houndmills, Basingstoke, England) 1996;1(5):288-95.
1996: Fred D Lublin; Stephen C Reingold
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Neurology 1996;46(4):907-11.
1996: Fred D Lublin; J N Whitaker; B H Eidelman; Aaron E Miller; B G Arnason; J S Burks
Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference.
Neurology 1996;46(1):12-8.
1995: Bernadette Kalman; Hansjuerg Alder; Fred D Lublin
Characteristics of the T lymphocytes involved in experimental allergic encephalomyelitis.
Journal of neuroimmunology 1995;61(2):107-16.
1995: Franca Cambi; L Tartaglino; Fred D Lublin; D McCarren
X-linked pure familial spastic paraparesis. Characterization of a large kindred with magnetic resonance imaging studies.
Archives of neurology 1995;52(7):665-9.
1995: Bernadette Kalman; Fred D Lublin; Hansjuerg Alder
Mitochondrial DNA mutations in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1995;1(1):32-6.
1995: J Joseph; R Kim; K Siebert; Fred D Lublin; C Offenbach; RL Knobler
Organ specific endothelial cell heterogeneity influences differential replication and cytopathogenicity of MHV-3 and MHV-4. Implications in viral tropism.
Advances in experimental medicine and biology 1995;380():43-50.
1994: Carlos F Gonzalez; T Swirsky-Sacchetti; D Mitchell; Fred D Lublin; R L Knobler; S M Ehrlich
Distributional patterns of multiple sclerosis brain lesions. Magnetic resonance imaging--clinical correlation.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 1994;4(4):188-95.
1994: Bernadette Kalman; RL Knobler; Fred D Lublin
Preferential but not exclusive T cell receptor V beta chain utilization of myelin basic protein and peptide-specific T cell clones in mice.
Cellular immunology 1994;153(1):206-13.
1993: RL Knobler; J I Greenstein; Kenneth P Johnson; Fred D Lublin; Hillel Panitch; K Conway; S V Grant-Gorsen; J Muldoon; S G Marcus; J C Wallenberg
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-up.
Journal of interferon research 1993;13(5):333-40.
1993: L M Jemison; Stuart K Williams; Fred D Lublin; RL Knobler; Robert Korngold
Interferon-gamma-inducible endothelial cell class II major histocompatibility complex expression correlates with strain- and site-specific susceptibility to experimental allergic encephalomyelitis.
Journal of neuroimmunology 1993;47(1):15-22.
1993: Bernadette Kalman; Fred D Lublin; E Lattime; J Joseph; RL Knobler
Effects of staphylococcal enterotoxin B on T cell receptor V beta utilization and clinical manifestations of experimental allergic encephalomyelitis.
Journal of neuroimmunology 1993;45(1-2):83-8.
1993: Bernadette Kalman; RL Knobler; Fred D Lublin
T cell receptor V beta gene utilization in myelin basic protein specific clones from CXJ1 recombinant inbred mice.
Journal of neuroimmunology 1993;43(1-2):191-4.
1993: J Joseph; J L Grun; Fred D Lublin; RL Knobler
Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4, JHM).
Journal of neuroimmunology 1993;42(1):47-52.
1993: J Joseph; J L Grun; Fred D Lublin; RL Knobler
Cytokine induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4, JHM).
Advances in experimental medicine and biology 1993;342():443-8.
1993: J Joseph; RL Knobler; Fred D Lublin; F R Burns
Regulation of the expression of intercellular adhesion molecule-1 (ICAM-1) and the putative adhesion molecule Basigin on murine cerebral endothelial cells by MHV-4 (JHM).
Advances in experimental medicine and biology 1993;342():389-91.
1993: J Joseph; M Nunez; J L Grun; Fred D Lublin; M N Hart; RL Knobler
Generation of an anti-mouse brain endothelial cell monoclonal antibody that recognizes 84-110 kDa and 36 kDa determinants that are upregulated by cytokines.
Advances in experimental medicine and biology 1993;331():249-54.
1993: Fred D Lublin; RL Knobler; Bernadette Kalman; M Goldhaber; J Marini; M Perrault; C D'Imperio; J Joseph; Sefik S Alkan; Robert Korngold
Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis.
Autoimmunity 1993;16(4):267-74.
1992: T Swirsky-Sacchetti; H L Field; D R Mitchell; J Seward; Fred D Lublin; R L Knobler; Carlos F Gonzalez
The sensitivity of the Mini-Mental State Exam in the white matter dementia of multiple sclerosis.
Journal of clinical psychology 1992;48(6):779-86.
1992: T Swirsky-Sacchetti; D R Mitchell; J Seward; C Gonzales; Fred D Lublin; RL Knobler; H L Field
Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis.
Neurology 1992;42(7):1291-5.
1992: Fred D Lublin; J C Marini; M Perreault; C Olender; C D'Imperio; J Joseph; Robert Korngold; RL Knobler
Autoimmune inflammation of astrocyte transplants.
Annals of neurology 1992;31(5):519-24.
1992: Fred D Lublin
Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity.
Current opinion in neurology and neurosurgery 1992;5(2):182-7.
1992: RL Knobler; J C Marini; D Goldowitz; Fred D Lublin
Distribution of the blood-brain barrier in heterotopic brain transplants and its relationship to the lesions of EAE.
Journal of neuropathology and experimental neurology 1992;51(1):36-9.
1991: S M Jones; L J Streletz; V E Raab; RL Knobler; Fred D Lublin
Lower extremity motor evoked potentials in multiple sclerosis.
Archives of neurology 1991;48(9):944-8.
1991: J Joseph; RL Knobler; Fred D Lublin; M N Hart
Mouse hepatitis virus (MHV-4, JHM) blocks gamma-interferon-induced major histocompatibility complex class II antigen expression on murine cerebral endothelial cells.
Journal of neuroimmunology 1991;33(3):181-90.
1990: J Joseph; RL Knobler; Fred D Lublin; M N Hart
Regulation of MHC class I and II antigens on cerebral endothelial cells and astrocytes following MHV-4 infection.
Advances in experimental medicine and biology 1990;276():579-91.
1989: J Joseph; RL Knobler; Fred D Lublin; M N Hart
Differential modulation of MHC class I antigen expression on mouse brain endothelial cells by MHV-4 infection.
Journal of neuroimmunology 1989;22(3):241-53.
1989: chris hall; V A Evans; Fred D Lublin; RL Knobler; Terry D Heiman-Patterson; Albert J Tahmoush; G Parry; P Schick; T G DeRyk
Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia.
Annals of neurology 1989;25(5):511-3.
1988: J Joseph; RL Knobler; C D'Imperio; Fred D Lublin
Down-regulation of interferon-gamma-induced class II expression on human glioma cells by recombinant interferon-beta: effects of dosage treatment schedule.
Journal of neuroimmunology 1988;20(1):39-44.
1988: G Barolat; RL Knobler; Fred D Lublin
Trigeminal neuralgia in a patient with multiple sclerosis treated with high cervical spinal cord stimulation. Case report.
Applied neurophysiology 1988;51(6):333-7.
1988: RL Knobler; Fred D Lublin; D S Linthicum; M Cohn; R D Melvold; Howard L Lipton; B A Taylor; W G Beamer
Genetic regulation of susceptibility and severity of demyelination.
Annals of the New York Academy of Sciences 1988;540():735-7.
1988: George C Brainard; M Watson-Whitmeyer; RL Knobler; Fred D Lublin
Neuroendocrine regulation of immune parameters. Photoperiod control of the spleen in Syrian hamsters.
Annals of the New York Academy of Sciences 1988;540():704-6.
1988: Fred D Lublin; RL Knobler; J Marini; D Goldowitz
Brain transplantation in genetic analysis of experimental allergic encephalomyelitis.
Annals of the New York Academy of Sciences 1988;540():252-4.
1988: RL Knobler; George C Brainard; M Perreault; C D'Imperio; P Phenix; Fred D Lublin
Immune effects of intracerebral infection with mouse hepatitis virus.
Annals of the New York Academy of Sciences 1988;540():642-4.
1988: RL Knobler; Fred D Lublin; L J Streletz; M Zimmer; J Joseph; C D'Imperio; B Northrup; G Barolat; S G Marcus
Intracerebral beta-interferon in brain tumor therapy. Monitoring cerebral function with compressed spectral analysis.
Annals of the New York Academy of Sciences 1988;540():573-5.
1988: J Joseph; C D'Imperio; RL Knobler; Fred D Lublin
Down-regulation of gamma-interferon-induced class II expression of human glioma cells by recombinant beta-interferon.
Annals of the New York Academy of Sciences 1988;540():475-6.